Episode 49
Biotech Hangout
00:00
You Can't Build Biotechs Without Great Co-Founders
The gravity of biotech has worked for the last 15 to 20 years, in part because of some of the things talked about from that has plagued big pharma. Almost no biotech ever sees revenues during its life as a private company and so valuations have come into an equilibrium around those numbers. And I would argue that Curie is not actually very different from that. They may be different in how they present that upfront story and how they work with founders and such.
Transcript
Play full episode
